NCT01658514View on ClinicalTrials.gov

Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Renal Insufficiency
Interventions
DRUG

Met DR

metformin delayed-release tablets

DRUG

Met XR

metformin extended-release tablets

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Elcelyx Therapeutics, Inc.

INDUSTRY